These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28774848)

  • 1. Reporting practices for variants of uncertain significance from next generation sequencing technologies.
    Vears DF; Sénécal K; Borry P
    Eur J Med Genet; 2017 Oct; 60(10):553-558. PubMed ID: 28774848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel.
    Vears DF; Sénécal K; Borry P
    Hum Mutat; 2017 Aug; 38(8):905-911. PubMed ID: 28512758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Points to consider for laboratories reporting results from diagnostic genomic sequencing.
    Vears DF; Sénécal K; Clarke AJ; Jackson L; Laberge AM; Lovrecic L; Piton A; Van Gassen KLI; Yntema HG; Knoppers BM; Borry P
    Eur J Hum Genet; 2018 Jan; 26(1):36-43. PubMed ID: 29184171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms.
    Vears DF; Niemiec E; Howard HC; Borry P
    Eur J Hum Genet; 2018 Dec; 26(12):1743-1751. PubMed ID: 30143804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACMG clinical laboratory standards for next-generation sequencing.
    Rehm HL; Bale SJ; Bayrak-Toydemir P; Berg JS; Brown KK; Deignan JL; Friez MJ; Funke BH; Hegde MR; Lyon E;
    Genet Med; 2013 Sep; 15(9):733-47. PubMed ID: 23887774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCMG practice guideline: laboratory guidelines for next-generation sequencing.
    Hume S; Nelson TN; Speevak M; McCready E; Agatep R; Feilotter H; Parboosingh J; Stavropoulos DJ; Taylor S; Stockley TL;
    J Med Genet; 2019 Dec; 56(12):792-800. PubMed ID: 31300550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories.
    O'Daniel JM; McLaughlin HM; Amendola LM; Bale SJ; Berg JS; Bick D; Bowling KM; Chao EC; Chung WK; Conlin LK; Cooper GM; Das S; Deignan JL; Dorschner MO; Evans JP; Ghazani AA; Goddard KA; Gornick M; Farwell Hagman KD; Hambuch T; Hegde M; Hindorff LA; Holm IA; Jarvik GP; Knight Johnson A; Mighion L; Morra M; Plon SE; Punj S; Richards CS; Santani A; Shirts BH; Spinner NB; Tang S; Weck KE; Wolf SM; Yang Y; Rehm HL
    Genet Med; 2017 May; 19(5):575-582. PubMed ID: 27811861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the ethical challenges of next-generation sequencing in genomic medicine.
    Clarke AJ
    Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing.
    Mack SJ; Milius RP; Gifford BD; Sauter J; Hofmann J; Osoegawa K; Robinson J; Groeneweg M; Turenchalk GS; Adai A; Holcomb C; Rozemuller EH; Penning MT; Heuer ML; Wang C; Salit ML; Schmidt AH; Parham PR; Müller C; Hague T; Fischer G; Fernandez-Viňa M; Hollenbach JA; Norman PJ; Maiers M
    Hum Immunol; 2015 Dec; 76(12):954-62. PubMed ID: 26407912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is NGS already in clinical use?].
    Jordan B
    Med Sci (Paris); 2011 Dec; 27(12):1127-30. PubMed ID: 22192753
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of a multidisciplinary team in managing variants of uncertain clinical significance in prenatal genetic diagnosis.
    Diderich KEM; Klapwijk JE; van der Schoot V; van den Born M; Wilke M; Joosten M; Stuurman KE; Hoefsloot LH; Van Opstal D; Brüggenwirth HT; Srebniak MI
    Eur J Med Genet; 2023 Oct; 66(10):104844. PubMed ID: 37709011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
    Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
    Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of laboratory reporting practices using a quality assessment of a virtual patient.
    Vears DF; Elferink M; Kriek M; Borry P; van Gassen KL
    Genet Med; 2021 Mar; 23(3):562-570. PubMed ID: 33122805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of genetic health professional - laboratory specialist interactions in diagnostic genomic sequencing.
    Vears DF; Sénécal K; Borry P
    Eur J Med Genet; 2020 Mar; 63(3):103749. PubMed ID: 31472303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.